These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 18279624)
61. Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion. Ye ZJ; Zhou Q; Gu YY; Qin SM; Ma WL; Xin JB; Tao XN; Shi HZ J Immunol; 2010 Nov; 185(10):6348-54. PubMed ID: 20952674 [TBL] [Abstract][Full Text] [Related]
62. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer. Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723 [TBL] [Abstract][Full Text] [Related]
63. Intrapleural hyperthermic perfusion using distilled water at 48 °C for malignant pleural effusion. Ba M; Long H; Wang Y; Tang Y; Wu Y; Zhang X; Cui S J Cancer Res Clin Oncol; 2013 Dec; 139(12):2005-12. PubMed ID: 24072234 [TBL] [Abstract][Full Text] [Related]
64. Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review. Zarogoulidis P; Chatzaki E; Hohenforst-Schmidt W; Goldberg EP; Galaktidou G; Kontakiotis T; Karamanos N; Zarogoulidis K Cancer Gene Ther; 2012 Sep; 19(9):593-600. PubMed ID: 22744209 [TBL] [Abstract][Full Text] [Related]
65. High IL-35 pleural expression in patients with tuberculous pleural effusion. Dong X; Yang J Med Sci Monit; 2015 May; 21():1261-8. PubMed ID: 25935866 [TBL] [Abstract][Full Text] [Related]
66. Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism. Lu Y; Lin H; Zhai K; Wang X; Zhou Q; Shi H Sci China Life Sci; 2016 Dec; 59(12):1297-1304. PubMed ID: 27535421 [TBL] [Abstract][Full Text] [Related]
67. Simple intrapleural hyperthermia at thoracoscopic exploration to treat malignant pleural effusion. Moon Y; Kim KS; Park JK J Cardiothorac Surg; 2015 Oct; 10():136. PubMed ID: 26510956 [TBL] [Abstract][Full Text] [Related]
68. Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion. Li X; Wu G; Chen C; Zhao Y; Zhu S; Song X; Yin J; Lv T; Song Y Front Immunol; 2021; 12():760683. PubMed ID: 34966384 [TBL] [Abstract][Full Text] [Related]
69. [The effect of intrapleural pingyangmycin administration on activity of fibrinolytic system and transforming growth factor-beta1 in malignant pleural effusion]. Zhu QQ; Sun GY Zhonghua Jie He He Hu Xi Za Zhi; 2009 Sep; 32(9):674-8. PubMed ID: 20079281 [TBL] [Abstract][Full Text] [Related]
70. The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer. Wu MF; Lin CA; Yuan TH; Yeh HY; Su SF; Guo CL; Chang GC; Li KC; Ho CC; Chen HW Cancer Immunol Immunother; 2021 May; 70(5):1435-1450. PubMed ID: 33175182 [TBL] [Abstract][Full Text] [Related]
71. Effect of ginseng polysaccharides and dendritic cells on the balance of Th1/Th2 T helper cells in patients with non-small cell lung cancer. Ma J; Liu H; Wang X J Tradit Chin Med; 2014 Dec; 34(6):641-5. PubMed ID: 25618966 [TBL] [Abstract][Full Text] [Related]
72. [Pleuritis carcinomatosa]. Miyanaga A; Gemma A Gan To Kagaku Ryoho; 2011 Apr; 38(4):524-7. PubMed ID: 21498978 [TBL] [Abstract][Full Text] [Related]
73. [Wedge resection and thermal cautery for malignant pleural effusion caused by lung cancer under vats]. Xia H; Yu CH; Zhang YM; Zhang W; Li YJ; Guo NN Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(11):775-7. PubMed ID: 21600106 [TBL] [Abstract][Full Text] [Related]
74. Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis. Yang G; Li H; Yao Y; Xu F; Bao Z; Zhou J Oncol Rep; 2015 Jan; 33(1):478-84. PubMed ID: 25371165 [TBL] [Abstract][Full Text] [Related]
75. Exogenous intrapleural injection of interleukin-27 may improves outcome and prognosis in patients with tuberculous pleural effusion. Gan Y; Guo S; Zhu Y; Jiang J; Tan Y Med Hypotheses; 2019 Oct; 131():109319. PubMed ID: 31443751 [TBL] [Abstract][Full Text] [Related]
76. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses. Sterman DH; Recio A; Carroll RG; Gillespie CT; Haas A; Vachani A; Kapoor V; Sun J; Hodinka R; Brown JL; Corbley MJ; Parr M; Ho M; Pastan I; Machuzak M; Benedict W; Zhang XQ; Lord EM; Litzky LA; Heitjan DF; June CH; Kaiser LR; Vonderheide RH; Albelda SM; Kanther M Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4456-66. PubMed ID: 17671130 [TBL] [Abstract][Full Text] [Related]
77. [Experimental and clinical studies on intrapleural instillations of interleukin-2 (IL-2) in patients with malignant pleural effusion]. Suzuki H Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1922-31. PubMed ID: 2608022 [TBL] [Abstract][Full Text] [Related]
78. Intrapleural perfusion thermo-chemotherapy for pleural effusion caused by lung carcinoma under VATS. Hu R; Jiang H; Li H; Wei D; Wang G; Ma S J Thorac Dis; 2017 May; 9(5):1317-1321. PubMed ID: 28616284 [TBL] [Abstract][Full Text] [Related]
79. Elevation of interleukin-10 levels in malignant pleural effusion. Chen YM; Yang WK; Whang-Peng J; Kuo BI; Perng RP Chest; 1996 Aug; 110(2):433-6. PubMed ID: 8697847 [TBL] [Abstract][Full Text] [Related]
80. Intrapleural hyperthermic perfusion chemotherapy in subjects with metastatic pleural malignancies. Işık AF; Sanlı M; Yılmaz M; Meteroğlu F; Dikensoy O; Sevinç A; Camcı C; Tunçözgür B; Elbeyli L Respir Med; 2013 May; 107(5):762-7. PubMed ID: 23462236 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]